BACKGROUND: Chronic hepatitis B infection is an important contributor to mortality in the United States, yet impact of available and effective oral antivirals on mortality among infected individuals is unknown. AIMS: To compare risks and predictors of mortality in a recent time period between those with chronic, prior and no hepatitis B infection. METHODS: This is a population-based cohort study of National Health and Nutrition Examination Surveys participants between 1999 and 2014 linked to National Death Index data. Adults aged 20 years or older with hepatitis B serologic testing were included. Outcomes of all-cause and liver-related mortality were evaluated using Cox regression. RESULTS: Of 39 206 participants, 192 (0.5%) had chronic and 2694 (6.9%) had prior hepatitis B infection. The all-cause age/sex-standardised mortality rates for chronic, prior and uninfected were 21.4, 15.1 and 11.8 per 1000 person-years respectively. Liver-related mortality occurred at respective rates of 4.1, 0.3 and 0.1 per 1000 person-years. In multivariable analyses, those with chronic infection had 1.9-fold (95% CI 1.1-3.3) increased hazard of all-cause mortality and 13.3-fold (95% CI 3.9-45.5) increased hazard of liver-related mortality compared to uninfected. Predictors of all-cause mortality among chronic infection included heavy alcohol use (HR 18.3, 95% CI 3.3-100.6) and higher alanine aminotransferase (HR 1.02, 95% CI 1.00-1.03). CONCLUSIONS: Mortality among adults living with chronic hepatitis B infection still exceeds that of uninfected despite availability of improved therapeutics. Identification of chronic infection, initiation of treatment among eligible and modulation of co-factors for disease progression are needed to improve survival.
BACKGROUND:Chronic hepatitis B infection is an important contributor to mortality in the United States, yet impact of available and effective oral antivirals on mortality among infected individuals is unknown. AIMS: To compare risks and predictors of mortality in a recent time period between those with chronic, prior and no hepatitis B infection. METHODS: This is a population-based cohort study of National Health and Nutrition Examination Surveys participants between 1999 and 2014 linked to National Death Index data. Adults aged 20 years or older with hepatitis B serologic testing were included. Outcomes of all-cause and liver-related mortality were evaluated using Cox regression. RESULTS: Of 39 206 participants, 192 (0.5%) had chronic and 2694 (6.9%) had prior hepatitis B infection. The all-cause age/sex-standardised mortality rates for chronic, prior and uninfected were 21.4, 15.1 and 11.8 per 1000 person-years respectively. Liver-related mortality occurred at respective rates of 4.1, 0.3 and 0.1 per 1000 person-years. In multivariable analyses, those with chronic infection had 1.9-fold (95% CI 1.1-3.3) increased hazard of all-cause mortality and 13.3-fold (95% CI 3.9-45.5) increased hazard of liver-related mortality compared to uninfected. Predictors of all-cause mortality among chronic infection included heavy alcohol use (HR 18.3, 95% CI 3.3-100.6) and higher alanine aminotransferase (HR 1.02, 95% CI 1.00-1.03). CONCLUSIONS:Mortality among adults living with chronic hepatitis B infection still exceeds that of uninfected despite availability of improved therapeutics. Identification of chronic infection, initiation of treatment among eligible and modulation of co-factors for disease progression are needed to improve survival.
Authors: Nizar A Mukhtar; Priya Kathpalia; Joan F Hilton; Gene Lau; Albert Yu; Kevin Grumbach; Tung T Nguyen; Daniel Chan; Mandana Khalili Journal: J Clin Gastroenterol Date: 2017-08 Impact factor: 3.062
Authors: Vy H Nguyen; An K Le; Huy N Trinh; Mimi Chung; Tiffani Johnson; Christopher Wong; Clifford Wong; Jian Zhang; Jiayi Li; Brian S Levitt; Huy A Nguyen; Khanh K Nguyen; Linda Henry; Ramsey Cheung; Mindie H Nguyen Journal: Clin Gastroenterol Hepatol Date: 2018-10-13 Impact factor: 11.382
Authors: Josepa Ribes; Ramon Clèries; Antoni Rubió; Josep Manel Hernández; Roberto Mazzara; Pedro Madoz; Teresa Casanovas; Aurora Casanova; Manel Gallen; Carmen Rodríguez; Victor Moreno; F Xavier Bosch Journal: Int J Cancer Date: 2006-08-01 Impact factor: 7.396
Authors: Donghee Kim; Andrew A Li; Chiranjeevi Gadiparthi; Muhammad Ali Khan; George Cholankeril; Jeffrey S Glenn; Aijaz Ahmed Journal: Gastroenterology Date: 2018-09-01 Impact factor: 22.682
Authors: Donghee Kim; Andrew A Li; Brandon J Perumpail; Chiranjeevi Gadiparthi; Won Kim; George Cholankeril; Jeffrey S Glenn; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed Journal: Hepatology Date: 2019-02-11 Impact factor: 17.425
Authors: Anne Liu; An Le; Jian Zhang; Chris Wong; Clifford Wong; Linda Henry; Mindie H Nguyen Journal: Clin Transl Gastroenterol Date: 2018-03-14 Impact factor: 4.488